Abemaciclib with fulvestrant for previously treated hormone receptor-positive HER2-negative advanced breast cancer [TSID12065]

  • In development
  • GID-TA11588
  • Expected publication date: TBC

38330-Abemaciclib-with-Fulvestrant-for-metastatic-breast-cancer-V1.0-MAY-2024-NON-CONF.pdf (nihr.ac.uk)